VV Manager LLC
CIK
1735804
Location
Boston, MA
Portfolio Value
Micro
$76,997,339
Diversification
Highly concentrated
Filing Date
Global Rank
#3,777
/ 5,297
▲ 364
Top Industry
Biotechnology
100.0%
3Y Alpha vs SPY
-51.5%
Period ended 5 years ago
Filed Aug 4, 2020 · 5y
2 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
-66.7%
SPY
+76.5%
Annualised alpha
-51.5%
Max drawdown
−84.1%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
1 positions · as of Jun 30, 2020 · Δ vs Mar 31, 2020Top Position
100.0%
0.0 pts
Top 5
100.0%
0.0 pts
Top 10
100.0%
0.0 pts
HHI
10,000
Highly concentrated0
Portfolio Trend
2 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2020| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $76,997,339 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increasedNo qualifying positions this quarter.
Trimmed
Positions the filer reduced
1 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| ALLO | Allogene Therapeutics, Inc. | −492,553 | 1,798,163 | $76,997,339 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarterNo qualifying positions this quarter.
Sold Out
Positions the filer fully exitedNo qualifying positions this quarter.
1 positions ·
$76,997,339 total
· as of Jun 30, 2020
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| ALLO |
Allogene Therapeutics, Inc.
Healthcare
|
Reduced | 1,798,163 | $76,997,339 | 100.00% |